Express Pharma Pulse

October 30, 2003

Sami Labs gets three patents, plans to enter formulations business

EPP News Bureau – Mumbai

Sami Labs Ltd, the Rs 250 crore Bangalore-based nutraceuticals and herbal extracts producer which has bagged three patents for tetrahydrocurcuminoids (THC), Coleus oil and ZeaLutien, is planning to enter the formulations segment in the country.

The company’s CMD Dr Muhammed Majeed said here today that they have asked Ernst and Young to chart out the consolidation of group companies and expansion of the company either through the IPO route or private investment.
Dr Majeed said he expects around Rs 200 crores to be pumped into the company to expand its marketing and research network.

Sami is also planning to enter the nutraceutical and ethical pharmaceutical formulations business in India in future. Sami is targeting a business of Rs 100 crores by 2006.

The company is working on four natural drug molecules which have cleared the toxicity screening, he said.

The company’s three new active ingredients - tetrahydrocurcuminoids (THC), Coleus oil and ZeaLutien have been approved for the dermatology, infective and geriatric ophthalmology markets.

THCs are the while curcuminoids converted from the yellow active ingredient from turmeric. The component has significant anti-oxidant application and UV protection. The process of conversion from yellow to white improves bioavailability and eliminates the staining properties of curcuminoids.

Lutien and its derivatives are used in ophthalmic drugs to treat age-related macular degeneration (AMD). The process of stabilisation of lutein improves longevity of the drug and its prevention of AMD oil extracted from Coeus Forskohli has strong anti-microbial properties especially in fighting gram positive infections and dental microbial activity.

He hopes to capture five per cent of the total global market in the netx three years with these discoveries.

A pioneer in the nutraceuticals industry, the company is a leading exporter of standardised herbal extracts, fine chemicals, specialty chemicals, cosmeceuticals, phytonutrients and probiotics.